Navigation Links
NW Bio Reaches 30 Clinical Trial Sites Ahead of End-of-Q1 Projection
Date:2/23/2012

BETHESDA, Md., Feb. 23, 2012 /PRNewswire/ -- Northwest Biotherapeutics (OTC.BB: NWBO) (NW Bio) today announced that it now has 30 clinical trial sites open and recruiting across the United States in its ongoing Phase 2 clinical trial of DCVax®-L immune therapy for Glioblastoma multiforme (GBM), the most lethal form of brain cancer.  The Company reached this milestone ahead of schedule, as the Company had projected to reach it by the end of Q1, 2012.  The Company likewise met or exceeded its projections in the three preceding quarters (Q2, Q3 and Q4 of 2011), as previously announced. 

(Logo: http://photos.prnewswire.com/prnh/20110329/SF73084LOGO)

The Company plans to continue adding clinical trial sites, and expects to have at least 40 sites open and enrolling by the end of Q2, 2012.  The Company will also continue pursuing its programs in Europe.  The open and active trial sites are listed on the U.S. Government's website, www.clinicaltrials.gov, and on NW Bio's website, www.nwbio.com

As previously stated, the Company's progress continues to reflect the growing interest from both physicians and patients, and a growing awareness of the positive data from the Company's prior clinical trials for GBM brain cancer.  In those trials, patients who received DCVax® showed a median survival of 3 years compared with median survival of 14.6 months for patients who received standard of care (surgery, radiation and chemotherapy).  Patients who received DCVax® also experienced a substantially longer time to tumor recurrence: a median of 2 years, compared with 6.9 months in patients who received standard of care.  DCVax® was well-tolerated, with no toxic side effects.

Linda Powers, CEO of NW Bio, commented that "Together with our r
'/>"/>

SOURCE Northwest Biotherapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Enrollment Reaches 110 Patients in Investigator Initiated, Randomized Trial of OrbusNeichs Genous(TM) Bio-Engineered R Stent(TM)
2. Arizona Heart Hospital Reaches Settlement Regarding Clinical Research Matter
3. CSL Behring Reaches Primary Endpoint in Clinical Study of C1-INH for Treatment of Hereditary Angioedema
4. Cancer Pioneer Reaches Key Agreement on Colon Cancer Drug OncoVAX(R)
5. CureHIV Reaches Out to Bill and Melinda Gates to Fund LiSAVIOR
6. Genmab Reaches Milestone in Ofatumumab Collaboration
7. Neurobiological Technologies Reaches Patient Enrollment Target For Interim Analysis of Viprinex(TM) Phase 3 Stroke Trials
8. AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108
9. Catalyst Reaches Enrollment Target for its U.S. Phase II Cocaine Trial
10. R&D Spending by U.S. Biopharmaceutical Companies Reaches Record Levels in 2008 Despite Economic Challenges
11. Terumo Heart, Inc. Reaches Clinical Milestone as the 100th Patient Worldwide Receives the DuraHeart(TM) Left Ventricular Assist System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... China , March 3, 2015 China ... or the "Company"), a leading retail drugstore chain in China based ... that the Company will report its unaudited financial results ... March 30, 2015 before the market opens. ... be simultaneously webcasted, on Monday, March 30, 2015 at ...
(Date:3/3/2015)... 2015  Immune Pharmaceuticals Inc. ("Immune", the "Company") (NASDAQ: ... Daniel Teper , Chief Executive Officer, will be presenting ... at 12:30 pm local time at the Ritz-Carlton in ... presentation will be webcast. To access the webcast, please ... Pharmaceuticals Inc. Immune Pharmaceuticals Inc. applies a ...
(Date:3/2/2015)... , March 2, 2015  Landauer, Inc. (NYSE: ... and environmental radiation measurement and monitoring, outsourced medical physics ... it will release financial results for the fiscal first ... 9, 2015. The Company will also ... 10, 2015 at 9:00 a.m. Central Time (10:00 a.m. ...
Breaking Medicine Technology:China Nepstar Chain Drugstore to Report Fourth Quarter and Fiscal Year 2014 Financial Results on March 30, 2015 2China Nepstar Chain Drugstore to Report Fourth Quarter and Fiscal Year 2014 Financial Results on March 30, 2015 3Immune Pharmaceuticals To Present At The Roth Conference 2Immune Pharmaceuticals To Present At The Roth Conference 3Landauer, Inc. Announces Date and Time for Announcement of Fiscal First Quarter 2015 Results and Conference Call 2
... Wash., June 1, 2011 BioLife Solutions, Inc. ... clinical grade biopreservation media products for cells and ... number and quality of life science organizations using ... now purchasing HypoThermosol® and/or CryoStor® to support the ...
... Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) announced ... Neurocrine Biosciences, will be presenting at the Jefferies 2011 Global ... live presentation takes place on Tuesday, June 7, 2011 at ... presentation will be webcast and may be accessed on the ...
Cached Medicine Technology:BioLife Solutions Announces Expanded Customer Base in the High Growth Regenerative Medicine Market 2BioLife Solutions Announces Expanded Customer Base in the High Growth Regenerative Medicine Market 3BioLife Solutions Announces Expanded Customer Base in the High Growth Regenerative Medicine Market 4
(Date:3/3/2015)... (PRWEB) March 03, 2015 The Data ... held at the Ford Conference Center, Dearborn, MI, on March ... Inc., is a featured speaker. He is known internationally ... Data.” , These designations were earned due to years ... 1st commercially-available NoSQL DB, released over 10 years ago. Subsequent ...
(Date:3/3/2015)... Spain (PRWEB) March 03, 2015 The authors ... best health care for the future is a good and ... by Xlibris UK) the authors have a created an ingenious ... & cooked vegetarian & vegan meals. , “Crude Food” ... food intolerances and allergies, mainly caused by over processed ...
(Date:3/3/2015)... NC (PRWEB) March 03, 2015 ... Dentist in Wilmington, NC has achieved Accredited ... Dentistry. , He achieved this accomplishment after ... oral examinations, as well as the submission of ... Edgerton of Wilmington, NC grew up in Connecticut, ...
(Date:3/3/2015)... 03, 2015 Aureus Medical Group (web: ... jobs, has announced that it will participate as an ... Tuesday, March 17, 2015 in St. Louis, MO. , ... meet job-seeking residents and fellows in a comfortable, relaxed ... will be available to speak with attendees about ...
(Date:3/2/2015)... 02, 2015 Formetco today announced the ... The FTX uses state-of-the-art technology to deliver an ... and owner satisfaction. An item of particular value, ... Formetco 10 year LED Brightness Warranty. , Why the ... a superior billboard among any other billboard product in ...
Breaking Medicine News(10 mins):Health News:Scientel® to Present at Data 360 Big Data Healthcare Conference, March 5, 2015, Dearborn, MI 2Health News:Scientel® to Present at Data 360 Big Data Healthcare Conference, March 5, 2015, Dearborn, MI 3Health News:Scientel® to Present at Data 360 Big Data Healthcare Conference, March 5, 2015, Dearborn, MI 4Health News:New book ‘Crude Food’ gives readers ingenious ways to create healthy meals 2Health News:New book ‘Crude Food’ gives readers ingenious ways to create healthy meals 3Health News:Dr. Edgerton, a Dentist in Wilmington, NC, Achieves Accredited Status in AACD 2Health News:Formetco Launches Innovative LED Billboard System 2
... 2008 The Procter &,Gamble Company (NYSE: PG ) ... September quarter to $22.0 billion. Organic sales were up five,percent, ... percent,target range. Sales growth was led by strong growth in ... Family Care segments. Diluted net earnings,per share increased 12 percent ...
... ConvaTec, a world-leading,developer and marketer of innovative medical ... Michael E. Steadman will join ConvaTec,as President of ... has been appointed as President of the company,s ... announced the formation of four new,operating divisions -- ...
... Sustainable Transition with SafePath,s ADA Approved, 100%,Recycled EntryLevel(TM) ... Oct. 29 For nearly 40 million,of-voting-age Americans ... just,a decision of who to vote for, rather, ... federal and state regulations mandating compliance for universal,access, ...
... DDS, has been selected for the 2008 Best of San Diego Award ... Association (USLBA). , ... San Diego (PRWEB) October 29, 2008 -- After ... been selected for the 2008 Best of San Diego Award in the ...
... is on course to reach $3.4 billion by 2012. Aging population, ... common chronic diseases represent the key market drivers. , ... ... of the vast parallel studies afforded by biochips have created a ...
... threat of Coronary Heart Disease joined by Royle Family star Ricky Tomlinson ... ... British men against the threat of Coronary Heart Disease (CHD) as part ... not take his heart health seriously in the past and paid the ...
Cached Medicine News:Health News:P&G Reports First Quarter EPS of $1.03 Up 12% on 9% Sales Growth 2Health News:P&G Reports First Quarter EPS of $1.03 Up 12% on 9% Sales Growth 3Health News:P&G Reports First Quarter EPS of $1.03 Up 12% on 9% Sales Growth 4Health News:P&G Reports First Quarter EPS of $1.03 Up 12% on 9% Sales Growth 5Health News:P&G Reports First Quarter EPS of $1.03 Up 12% on 9% Sales Growth 6Health News:P&G Reports First Quarter EPS of $1.03 Up 12% on 9% Sales Growth 7Health News:P&G Reports First Quarter EPS of $1.03 Up 12% on 9% Sales Growth 8Health News:P&G Reports First Quarter EPS of $1.03 Up 12% on 9% Sales Growth 9Health News:P&G Reports First Quarter EPS of $1.03 Up 12% on 9% Sales Growth 10Health News:P&G Reports First Quarter EPS of $1.03 Up 12% on 9% Sales Growth 11Health News:P&G Reports First Quarter EPS of $1.03 Up 12% on 9% Sales Growth 12Health News:P&G Reports First Quarter EPS of $1.03 Up 12% on 9% Sales Growth 13Health News:P&G Reports First Quarter EPS of $1.03 Up 12% on 9% Sales Growth 14Health News:P&G Reports First Quarter EPS of $1.03 Up 12% on 9% Sales Growth 15Health News:P&G Reports First Quarter EPS of $1.03 Up 12% on 9% Sales Growth 16Health News:P&G Reports First Quarter EPS of $1.03 Up 12% on 9% Sales Growth 17Health News:ConvaTec Names Presidents of Wound Therapeutics and Ostomy Care Business Units 2Health News:SafePath(TM) Products Provides Universal Access for Ohio Voters 2Health News:Dr. Ron Greenspan has Been Selected for the 2008 Best of San Diego Award in the Orthodontists Category by the U.S. Local Business Association 2Health News:Dr. Ron Greenspan has Been Selected for the 2008 Best of San Diego Award in the Orthodontists Category by the U.S. Local Business Association 3Health News:World Biochips Market to Reach $3.4 billion by 2012, According to New Report by Global Industry Analysts, Inc. 2Health News:World Biochips Market to Reach $3.4 billion by 2012, According to New Report by Global Industry Analysts, Inc. 3Health News:Ricky Tomlinson Joins Lloydspharmacy Against Coronary Heart Disease 2Health News:Ricky Tomlinson Joins Lloydspharmacy Against Coronary Heart Disease 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: